Janus kinase inhibitors - their current applications and future prospects
Janus kinase inhibitors are a group of drugs that provide an alternative to conventional therapy for numerous diseases. The most studied drug of this group is tofacitinib. They are used in cases of inadequate response to treatment, intolerance of first-line drugs or presence of severe side effects r...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Polish |
| Published: |
Polish Pharmaceutical Society
2022-09-01
|
| Series: | Farmacja Polska |
| Subjects: | |
| Online Access: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F7%2F03_OG_Kinazy_janusowe_n.pdf |